Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Sedation × Midazolam × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 3 Neoplasms 3 Lung Neoplasms 3 Breast Neoplasms 3 Pain 2 Colonic Neoplasms 2 Choledochal Cyst 2 Urinary Bladder Neoplasms 1 Terminal Cancer 1 Solid Tumor 1 Skin Neoplasms 1 Sedation 1 Rectal Neoplasms 1 Postoperative Cognitive Complications 1 Polyps 1 Patient Satisfaction 1 Pancreatic Neoplasms 1 Pain, Postoperative 1 Pain, Intractable 1 Opioid-Related Disorders 1 Nausea 1 Mouth Neoplasms 1 Healthy 1 Glioma 1 Gastrointestinal Stromal Tumors 1 Fractures, Bone 1 Female Patients Under the Age of 65 Who Will Undergo Breast Cancer Surgery 1 Emergence Delirium 1 Dyspnea 1 Diverticulosis, Colonic 1

Interventions

Propofol 1 Midazolam 1 Dexmedetomidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03343873 2024-08-01

ACTION

Beijing Tiantan Hospital

Phase NA Recruiting

Sedation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡